Form 6-K SONY CORP For: Nov 20
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of�November 2014
Commission File Number: 001-06439
SONY CORPORATION
(Translation of registrant's name into English)
1-7-1 KONAN, MINATO-KU, TOKYO, 108-0075, JAPAN
(Address of principal executive offices)
The registrant files annual reports under cover of Form 20-F.
Indicate by check mark whether the registrant�files or will file annual reports under cover of Form 20-F or Form 40-F,
�
Form 20-F��X
|
Form 40-F __
|
�
Indicate by check mark whether the�registrant�by�furnishing�the�information contained�in this�Form is�also�thereby�furnishing�the�information�to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934, Yes No X
�
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):82-______
�
SIGNATURE
Pursuant�to the�requirements�of the�Securities�Exchange�Act of�1934,�the registrant�has duly�caused�this�report�to be�signed�on its�behalf by the undersigned, thereunto duly authorized.
�
� |
SONY CORPORATION
|
� |
(Registrant)
|
� | � |
� | � |
� |
By:��/s/��Kenichiro Yoshida
|
� |
����������������(Signature)
|
� |
Kenichiro Yoshida
|
� |
Executive Vice President and
|
� |
Chief Financial Officer
|
�
Date:�November 20, 2014
List of materials
Documents attached hereto:
�
i) Press release�announcing Determination of Final Terms of Stock Acquisition Rights for the Purpose of Granting Stock Options
�
�
�
�
�
�
�News & Information |
1-7-1 Konan, Minato-ku
Tokyo, 108-0075 Japan
|
�
�
November 20, 2014
Determination of Final Terms of Stock Acquisition Rights
for the Purpose of Granting Stock Options
�
Sony Corporation (the Corporation) announced today that the final terms of stock acquisition rights (Stock Acquisition Rights) for the purpose of granting stock options, which issues were resolved at the meeting of its Board of Directors held on October 30, 2014, have been fixed as set forth below.
The Twenty-Eighth Series of Stock Acquisition Rights
�
1. Aggregate number of Stock Acquisition Rights:
8,804
2. Persons to whom Stock Acquisition Rights will be allocated and number of Stock Acquisition Rights to be allocated:
|
� | � |
Number of persons
|
||
� | � |
(Number of Stock Acquisition Rights)
|
||
Corporate executive officers of the Corporation
|
� |
7
|
� |
(2,500)
|
Employees of the Corporation
|
� |
158
|
� |
(3,068)
|
Directors of the subsidiaries of the Corporation
|
� |
67
|
� |
(1,608)
|
Employees of the subsidiaries of the Corporation
|
� |
136
|
� |
(1,628)
|
� | � |
Total: 368
|
� |
(Total: 8,804)
|
�
3. Payment in exchange for Stock Acquisition Rights:
Stock Acquisition Rights are issued without payment of any consideration to the Corporation.
�
4. Class and number of shares to be issued or transferred upon exercise of Stock Acquisition Rights:
880,400 shares of common stock of the Corporation
The number of shares to be issued or transferred upon exercise of each Stock Acquisition Right shall be 100 shares.
5. Amount of assets to be contributed upon exercise of Stock Acquisition Rights:
241,050 yen per Stock Acquisition Right
(2,410.5 yen per share) (Exercise Price)
�
1/2
�
�
�
The Twenty-Ninth Series of Stock Acquisition Rights
1. Aggregate number of Stock Acquisition Rights:
10,120
�
2. Persons to whom Stock Acquisition Rights will be allocated and number of Stock Acquisition Rights to be allocated:
|
�
�
|
� | � | � | � |
� | � |
Number of persons
|
||
� | � |
(Number of Stock Acquisition Rights)
|
||
Corporate executive officers of the Corporation
|
� |
1
|
� |
(2,000)
|
Employees of the Corporation
|
� |
1
|
� |
(���� 10)
|
Directors of the subsidiaries of the Corporation
|
� |
23
|
� |
(2,716)
|
Employees of the subsidiaries of the Corporation
|
� |
533
|
� |
(5,394)
|
� | � |
Total: 558
|
� |
(Total: 10,120)
|
�
3. Payment in exchange for Stock Acquisition Rights:
Stock Acquisition Rights are issued without payment of any consideration to the Corporation.
�
4. Class and number of shares to be issued or transferred upon exercise of Stock Acquisition Rights:
1,012,000 shares of common stock of the Corporation
The number of shares to be issued or transferred upon exercise of each Stock Acquisition Right shall be 100 shares.
5. Amount of assets to be contributed upon exercise of Stock Acquisition Rights:
2,067.00 U.S. dollars per Stock Acquisition Right
(20.67 U.S. dollars per share) (Exercise Price)
�
2/2
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CIDARA Therapeutics ALERT: Bragar Eagel & Squire, P.C. is Investigating Cidara Therapeutics, Inc. on Behalf of Cidara Therapeutics Stockholders and Encourages Investors to Contact the Firm
- Banco Itaú Chile Files Material Event Notice announcing Extraordinary General Shareholders’ Meeting Agreements
- ROSEN, A TOP RANKED LAW FIRM, Encourages CI&T Inc Investors to Inquire About Securities Class Action Investigation – CINT
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!